The following account reviews the work that has been carried out on the natriuretic hormone since 1977, when a previous Editorial Review on this subject appeared [l].
Further evidence for the presence of a natriuretic substance in untreated plasma Knock 8z de Wardener [2] confirmed the results of the Sonnenberg et al. [31 experiment in which a donor rat is isovolaemically cross circulated with a recipient assay rat. When the blood volume of the donor rat was increased with homologous blood the urinary sodium excretion of the recipient assay rat, the blood volume of which did not change, rose briskly for 1 h and then returned slowly towards the control value during the next 1-2 h. This occurred only if the urine of the donor rat was reinfused from the time the blood volume was expanded.
Knock 141 modified a previous experiment by Pearce et al. [51 and showed that a small amount of plasma from a volume expanded animal when injected into another animal causes a prolonged natriuresis. It was first shown that blood volume expansion with equilibrated blood in the rat causes a brisk rise in urinary sodium excretion, which is maximal at about 1 h. Blood (2 ml) was removed from the volume expanded rat at the height of the natriuresis, it was centrifuged and the resultant 1 ml of plasma injected within a few minutes into another rat. This caused a small but significant natriuresis, which began after 1 h and was still increasing 2 h later. The natriuresis was more pronounced if the animal donating the blood had had its urine reinfused. Plasma (1 ml) from a control rat, the blood volume of which was not expanded, did not cause a rise in urinary sodium excretion when injected into another rat.
Correspondence: Professor H. [71 have demonstrated that the limited capacity of the young prepubertal rat to excrete a sodium load is probably related to the absence of a circulating natriuretic substance. Young rats were given a transfusion of blood obtained either from rats of the same age, or from adult rats. Both transfusions were followed by a brisk natriuresis but the rise in urinary sodium excretion was considerably greater when the transfusion was performed with blood obtained from adult rats.
Evidence that the natriuretic substance in the plasma may be a Na+,K+-ATPase inhibitor These experiments have been performed with both untreated plasma and extracts of plasma.
Poston et al. [81 measured the effect on leucocyte sodium transport of plasma from normal subjects before and after they had been given 9a-fludrocortisone, and had 'escaped' from its effect. The leucocyte efflux rate constant fell substantially, owing to a significant fall in the ouabain sensitive efflux rate constant. There was an insignificant fall in the ouabain insensitive rate constant. Total sodium efflux rate constant of normal leucocytes incubated in the plasma of subjects who had escaped from the effect of 9a-fludrocortisone also fell significantly. In contrast the sodium efflux rate constant of leucocytes from normal control subjects incubated in serum obtained from other normal subjects did not change. These results suggest that the circulating sodium transport inhibitor demonstrated by others in previous experiments affects leucocytes, and does so by inhibiting Nat,KtATPase. This conclusion was confirmed by de Wardener et al. [91, who used a quantitative cytochemical technique to measure Na+,K+-ATPase in intact cells of guinea pig kidneys in uitro. They first established that purified low molecular weight urinary natriuretic extract inhibited Na+,K+-ATPase in intact cells at 6 min in a log dose linear manner, and that in this cytochemical system a 1 : 100 sample of normal human plasma produced maximal inhibition of Na+,K+-ATPase. They then found that the capacity of plasma to inhibit the ouabain sensitive component of Na+,K+-ATPase activity was approximately 25 times greater when the plasma was obtained from subjects on a high sodium diet than when the same subjects were on a low sodium diet. As inhibition of Na+,K+-ATPase stimulates glucose 6-phosphate dehydrogenase (G6PD) activity [lo] , and as the quantitative cytochemical technique used to measure G6PD activity in intact cells is well established and has been in use for several years, Fenton et al. [ 111 have developed an assay to measure the capacity of biological fluids to stimulate G6PD activity in intact cells in uitro as a marker of their ability to inhibit Na+,K+-ATPase activity. Using this technique Fenton et al. [ 111 have found that the purified natriuretic extract stimulated G6PD at high dilutions, and that plasma from salt loaded subjects stimulated G6PD activity about 20 times more than plasma from the same subjects on a low sodium diet. The time course of the changes in Na+,K+-ATPase and G6PD activity induced by the natriuretic extract and plasma were similar, and the rise in G6PD activity induced by a wide range of concentrations of natriuretic extract and plasma were parallel. The identity of these two phenomena suggest that the substance responsible for the fall in Na+,K+-ATPase and the rise in G6PD activity in the natriuretic extract and the plasma are chemically similar.
Gonick et al. [121 obtained plasma from rats before and after infusion of sodium chloride solution (saline). It was then fractionated on G25 Sephadex in Tris/HCl (0.1 mol/l). They found that material from plasma obtained after saline infusion, which appeared after the main peak of salt and was thus presumed to be of low molecular weight, inhibited Na+,K+-ATPase in a homogenate of whole kidney. Gruber et al.
13-151 have prepared a highly purified extract of plasma, obtained from dogs before and after an infusion of saline, which decreased the short circuit current across the toad bladder, inhibited an isolated membrane preparation of hog brain Na+,K+-ATPase and cross-reacted with digoxin antibody. These properties were more evident in extracts of plasma obtained after saline infusion.
Site of production
The site of production of the natriuretic hormone is not known. In addition to the work of Kaloyannides et al., which was mentioned previously 11, there are two other whole animal experimental studies which also suggest that the brain or more specifically the hypothalamus is involved in urinary sodium excretion. There are also several fresh reports that extracts of hypothalamus or whole brain contain a Na+,K+-ATPase inhibitor. Silva-Netto et al. [ 161 injected carbachol into the anterior lateral part of the rat hypothalamus through an implanted cannula. There followed a natriuresis associated with a significant reduction in filtration fraction and no change in glomerular filtration rate. Pamnani et al. [171, who measured 86Rb uptake of segments of arteries incubated in plasma as an index of the plasma's capacity to influence Na+,K+-ATPase, found that anteroventral lesions of the third ventricle abolished the usual rise in the plasma's capacity to inhibit Na+,K+-ATPase, which occurs with volume expansion.
Haupert & Sancho 1181 obtained a material from bovine hypothalamus which inhibited both toad bladder sodium transport and I3H]ouabain binding to frog bladder, and also inhibited isolated membrane preparations of rabbit renal Na+,K+-ATPase. The material, which was referred to throughout as 'natriuretic factor', was not, however, assayed for nitriuretic activity. homogenized rat hypothalamus in acetone and assayed the acetone extracts for their ability to stimulate G6PD activity in intact cells [ 111. The hypothalami were obtained from rats which had been given a low, normal or high salt diet for 4 weeks beforehand. They found that the hypothalamic extracts contained large amounts of G6PD stimulating activity, whereas extracts similarly prepared from other tissues were inactive. The stimulation had the same time response and dose relationship as that produced by plasma and by the urine extract prepared by Clarkson et al. [221. The extracts prepared from the hypothalami of rats on a high salt intake had approximately 150 times more activity than those prepared from rats on a low salt diet.
Possible afferent mechanism
One of the afferent limbs which monitors blood volume and thus may control the secretion of natriuretic hormone is the intrathoracic blood volume, particularly the left atrial pressure [231. Total blood volume expansion increases intrathoracic blood volume and central venous pres-sure [241. The overriding importance of the intrathoracic blood volume in causing the ensuing rise in urinary sodium excretion has been demonstrated by experiments in which a man in the sitting position is immersed in water 1251. This manoeuvre induces a maintained increase in intrathoracic blood volume 126, 271 and a sustained increase in urinary sodium excretion despite a gradual decrease in total blood volume [28, 291. The intrathoracic blood volume of a man immersed while sitting in water is approximately 700 ml greater than when he is standing.
One-quarter of this volume is in the heart and most of it is in the atria [271. It is probable that it is the accompanying rise in left atrial pressure which causes the natriuresis [30, 3 11, for a rise in right atrial pressure causes an antinatriuresis
The time course and extent of the fall in aldosterone which occurs in a man immersed in water make it unlikely that it is this change which causes the natriuresis [33, 291. In the conscious dog in which the left atrial pressure can be raised by means of a snare, which induces a reversible mitral stenosis, the accompanying brisk rise in urinary sodium excretion is due to a fall in tubular sodium reabsorption. It can occur without any change in either total or regional renal blood flow 1341, in the adrenalectomized dog Isolation and chemical properties of natriuretic substances and sodium transport inhibitors in extracts of plasma, urine and brain Of the numerous reports during the past 20 years which have described natriuretic or antinatriferic substances in plasma and urine obtained in greater amounts after saline infusion, or blood transfusion, two active substances have been demonstrated, one with a molecular weight greater than 30000 and the other of less than 1000. In the past 5 years, however, there has been only one further study on a substance with a molecular weight greater than 30 OOO. Veress et al.
[411 explored the nature of such a substance, which they had previously obtained from plasma [421. Plasma was fractionated on G200 Sephadex using an eluent containing molar sodium chloride which was designed to dissociate low molecular weight substances bound to proteins. Natriuretic activity eluted in a fraction which when desalted on G25 Sephadex appeared after the salts and was thus likely to be of low molecular weight. This is the only convincing evidence in support of the proposition that the large molecular weight substance may be a precursor of the smaller substance [13,43-451.
In contrast there have been several further reports on the smaller molecular weight material. Gruber & Buckalew [13, 141 and Gruber et al. [ 151 deproteinized plasma by boiling for 20 min at pH 5 and then ultrafiltered the supernatant using a continuous flow technique through an Amicon UM 10 membrane in acetic acid (0.05 mol/l). Freeze-dried ultrafiltrates were gel filtered on Biogel P2 in acetic acid (1 mol/l), when antinatriferic activity was eluted in the post salt fraction. Further purification procedures included high performance liquid chromatography on a cation exchange resin and rechromatography of the active fraction on a reverse phase column.
Eluates were monitored with fluorescamine by using a stream sampling device which enabled small aliquots of the eluate to react with fluorescamine at predetermined intervals. The emitted fluorescence was measured in a fluorimeter. The reaction was carried out at a pH optimal for the formation of peptide fluophors, and thus it was claimed that material recording in this way must consist of peptides. A fraction was eluted with the void volume of the cation exchange column which decreased the short circuit current across the toad bladder, inhibited isolated membrane preparations of hog brain Na+,K+-ATPase, and cross reacted with digoxin antibody. The activity in this fraction was destroyed by incubation with trypsin but was resistant to chymotrypsin. It was also destroyed by acid hydrolysis. Gruber el al. [151 concluded from these findings that the active substance they had purified from the plasma was an acidic peptide.
In the past 5 years there have been several reports on a small molecular weight substance obtained from the urine. Clarkson et al. 1461 have studied extracts from normal man. Freeze-dried urine was fractionated on G25 Sephadex, when the natriuretic material eluted after the salts (F4). This material was soluble in more polar organic solvents such as methanol and ethanol and insoluble in chloroform and ether. It was filtrable through a 500 Amicon filter and moderately resistant to prolonged acid hydrolysis and to heating at 100°C for 1 h at pH 10. The activity was totally destroyed by nitrous acid but it was unaffected by incubation for long periods with eight different proteolytic enzymes. Nevertheless it was totally destroyed by an impure preparation of renal prolidase. This effect may have been due to a contaminant enzyme which was not necessarily proteolytic. Catecholamines were not detected with an assay sensitive to 50 pg/ml, and the natriuretic activity survived incubation with monamine oxidase both before and after deconjugation with arylsulphatase and /3-glucuronidase. The pattern of natriuretic response to increasing quantities of this material suggests saturation of receptor sites and is in contrast to that of a toxic substance such as vanadate. More recently Clarkson et al. [ 221 have accumulated several grams of F4, which are then taken through various simple purification procedures ending with cation exchange chromatography in a linear ionic gradient. These manoeuvres increase the specific activity of the natriuretic material approximately 1000-fold. The material is then further purified by organic solvent extraction and reverse phase high performance liquid chromatography, when a fraction is obtained which is suitable for structural analysis. The substance obtained in this way has a molecular weight below 400 and is basic. It contains no amino acids and cross reacts with digoxin antibodies. Clarkson et al. [ 221 have concluded that the material they have obtained from urine is not a peptide.
Fenton et al. [ 111 have found that this highly purified urinary material inhibits Na+,K+-ATPase in intact renal cells [ 1 11 and, assuming a molecular weight of 400 that, on intact cells it is at least 3000 times more potent than ouabain. In contrast E. M. Clarkson, V. Luck and H. E. de Wardener (unpublished observation) have found that the inhibiting activity of the urinary material on an isolated membrane fraction of Nat,KtATPase is about the same as that of ouabain.
Licht et al. [ 471 have purified F4 obtained from the urine of mineralocorticoid 'escaped' dogs using cation exchange and reverse phase high performance liquid chromatography. The eluates were monitored throughout with fluorescamine labelling similar to that used by Gruber et al. [151. Of the two major fluorescing peaks obtained with the last separation step, the peak which exhibited spontaneous fluorescence was inactive, the peak that exhibited fluorescamine dependent fluorescence was a potent inhibitor of sodium transport across the isolated toad bladder. But more recently the same workers have reported that in the material obtained from the urine of uraemic man by the same technique, the peak that did exhibit natural fluorescence inhibited sodium transport of 3T6 fibroblasts. They concluded that this activity was unlikely to be due to a peptide.
Kramer et al.
[481 have also obtained F4 from the urine of salt loaded subjects. This has been refractionated on another gel and then subjected to ion exchange and reverse phase high performance liquid chromatography. These workers concluded that the natriuretic activity was due to a small acidic peptide but no details were given to substantiate this conclusion.
In three of the four studies in which extracts were prepared from the brain some information about the chemical properties of the sodium transport inhibitor was obtained. Haupert & Sancho [ 181 homogenized large quantities of bovine hypothalamus in acetic acid and, after extracting with acetone and ether, fractionated the extract on G25 Sephadex in acetic acid (0.1 mol/l). The active material was found in the first portion of the salt peak. After desalting by means of a cation exchange resin the active material was found to be of low molecular weight, basic and unlikely to be a peptide, in that its activity was resistant to acid hydrolysis. Fishman [ 191 extracted whole guinea pig brain into acetone, removed the lipids with ether and fractionated the extract on G10 Sephadex, when the activity eluted with the salts. The active material was desalted on a mixed bed resin and was found to be of low molecular weight and resistant to acid hydrolysis. Lichstein & Samuelov [201 extracted whole rat brain into acid acetone. After removal of the acetone under reduced pressure and the insoluble residue by centrifugation, the extract was freezedried and extracted with methanol. The methanol soluble fraction inhibited rat synaptosomal Na+,K+-ATPase. It was soluble in trichloroacetic acid and resisted digestion with proteolytic enzymes. When fractionated on G25 Sephadex in Tris/HCl (0.05 mol/l) the inhibitor appeared to elute with the first part of the salt peak, and was thus assumed to be of low molecular weight.
Conclusions
The initial experiments on the natriuretic hormone demonstrated that the plasma of a volume expanded animal was natriuretic 111. It was then shown that normal plasma has the capacity to inhibit sodium transport and that this inhibitory capacity is greatest in plasma obtained from a volume expanded animal. It is now apparent that the sodium transport inhibitory capacity of plasma is due to its ability to inhibit Na+,K+-ATPase and, as a first approximation, it is assumed that the natriuretic capacity of the plasma obtained from a volume expanded man or animal, and its increased capacity to inhibit Na+,K+-ATPase, are due to a change in the concentration of the same substance. It has also been possible to obtain highly purified extracts of urine which are natriuretic and inhibit Na+,K+-ATPase and which are more potent when the urine comes from a volume expanded man or animal. There is also one report that the hypothalamus contains a substance which inhibits Na+,K+-ATPase, the concentration of which rises when the rat has been on a high intake of sodium.
It is interesting that, although it was early suspected that the circulating sodium transport inhibitor's activity might be due to its ability to inhibit Na+,K+-ATPase, and though now this suspicion has been demonstrated to be correct, most investigators measured and have continued to measure the effect of plasma or extracts of urine and brain on the sodium transport of intact cells instead of on the activity of preparations of isolated membrane or microsomal ATPase. This is probably because the Na+,K+-ATPase of an intact cell is more sensitive to the circulating sodium transport inhibitor than is the Na+.K+-ATPase of an isolated enzyme preparation. In our own experience we have found that the Na+,K+-ATPase of intact renal cells is much more sensitive to a highly purified extract of urine than the Na+,K+-ATPase of a microsomal preparation of kidney Na+,K+-ATPase [ 1 1 1. And whereas a 1:lOO dilution of plasma will induce a well marked inhibition of Na+,K+-ATPase in an intact renal cell it has no effect on isolated microsomal ATPase [9; E. M. Clarkson & H. E. de Wardener, unpublished observation]. In the same way the amount of urinary extract needed to depress the ouabain sensitive sodium efflux from intact leucocytes is considerably less than that needed to inhibit isolated microsomal Na+,K+-ATPase (L. Poston & E. M. Clarkson, unpublished observations).
The sodium transport inhibitors in mammalian plasma, urine and brain have properties similar to those of the cardiac glycosides derived from plants, in that they inhibit Na+,K+-ATPase, displace ouabain bound to cellular membranes and cross-react to a certain extent with digoxin antibody. On the other hand, the ability of the mammalian substances to inhibit Na+,Ki--ATPase in intact cells (assuming a molecular weight of 400) is at least 3000 times greater than the plant glycoside, ouabain I 1 1, 151. There are other differences. Ouabain has little natriuretic effect, and the inhibitory effect of the mammalian sodium transport inhibitors on the Na+,K+-ATPase of intact renal cells is short lived, as though the substance responsible were rapidly metabolized, whereas the effect of ouabain is sustained I1 11.
The chemical properties of the material extracted from the plasma by Gruber et al. I 15 I suggest that the activity of the plasma substance is due to a peptide, whereas the properties of the materials extracted from the urine 122, 471 and brain 118-201 suggest that the activity of the urinary and brain substances are not due to peptides.
Nevertheless cytochemical studies I1 11 show that the time response and the log dose-response of Na+,K+-ATPase activity to plasma and to urinary and hypothalamic extracts are similar, which suggests that the active substances in the blood, urine and brain are closely related.
